Back
Alnylam Pharmaceuticals Stock Predictions
Sponsored
ALNY
Sponsored
This Tech Company Grew 32,481%...
This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
27
ALNY
Alnylam Pharmaceuticals
Last Price:
$243.38
Seasonality Move:
2.78%
7 Day Trial
ALL ACCESS PASS
$
7
2025 Gold Forecast: A Perfect Storm for Demand
Discover our Gold Price Outlook for 2025--FREE--hereAlnylam Pharmaceuticals Stock Forecast
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 37.1% based on the past 20 years of stock performance.
-
Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
-
Is Alnylam Pharmaceuticals Stock Undervalued?The current Alnylam Pharmaceuticals [ALNY] share price is $243.25. The Score for ALNY is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
-
ALNY is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
Will Alnylam Pharmaceuticals Stock Go Up Next Year?
-
Over the next 52 weeks, Alnylam Pharmaceuticals has on average historically risen by 37.1% based on the past 20 years of stock performance.
Alnylam Pharmaceuticals Stock Rating
Sell
27
Alnylam Pharmaceuticals (ALNY)
is a Sell
Is Alnylam Pharmaceuticals overpriced?
-
Alnylam Pharmaceuticals has risen higher in 12 of those 20 years over the subsequent 52-week period, corresponding to a historical accuracy of 60%
Alnylam Pharmaceuticals Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
alnylam.com
52-Week Data
52-Week High:
304.39
52-Week Low:
141.98
Prediction Charts
Market Cap:
31.4B
Price in USD:
243.25
Volume:
253.1K
Beta:
1.18
Technical Analysis
SMA50:
262.53
SMA100:
265.89
SMA200:
221.39
52-Wk Change:
27.34%
Stock Predictions
-
Is Alnylam Pharmaceuticals stock public?Yes, Alnylam Pharmaceuticals is a publicly traded company.
-
What is the Alnylam Pharmaceuticals stock quote today?The Alnylam Pharmaceuticals stock price is 243.25 USD today.
-
How to buy Alnylam Pharmaceuticals stock online?You can buy Alnylam Pharmaceuticals shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
Date | Opening | Closing | Minimum | Maximum |
---|---|---|---|---|
Dec-5 | 252.99 | 251.81 | 255.29 | 250.21 |
Dec-6 | 251.60 | 256.26 | 257.81 | 250.65 |
Dec-9 | 255.39 | 255.89 | 258.12 | 252.20 |
Dec-10 | 257.72 | 253.91 | 257.99 | 250.33 |
Dec-11 | 254.50 | 254.15 | 255.92 | 250.21 |
Dec-12 | 255.02 | 245.26 | 255.47 | 244.84 |
Dec-13 | 246.01 | 245.44 | 249.51 | 241.89 |
Dec-16 | 246.44 | 243.99 | 247.93 | 242.13 |
Dec-17 | 242.70 | 246.58 | 249.58 | 240.42 |
Dec-18 | 245.67 | 237.92 | 247.05 | 237.25 |
Dec-19 | 238.11 | 238.87 | 242.87 | 233.41 |
Dec-20 | 239.45 | 245.50 | 247.21 | 235.93 |
Dec-23 | 244.63 | 242.26 | 244.64 | 237.12 |
Dec-24 | 241.70 | 243.25 | 243.90 | 236.70 |
Alnylam Pharmaceuticals Earnings
Alnylam Pharmaceuticals Earnings Report: Per Share Alnylam Pharmaceuticals Earnings Q1 Q2 Q3 and Q4 last year and next year.
Alnylam Pharmaceuticals Forecast Revenue Growth
Alnylam Pharmaceuticals Stock Analysis: Historical quarterly revenues per share for Alnylam Pharmaceuticals and historical quarterly revenue growth:
-
Analysts estimate an earnings increase this quarter of $0.86 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.45 per share, and an increase next year of $0.71 per share.
* Alnylam Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.